Literature DB >> 24600991

Hsa-mir-182 downregulates RASA1 and suppresses lung squamous cell carcinoma cell proliferation.

Yan-Jun Zhu1, Biao Xu2, Wei Xia3.   

Abstract

BACKGROUND: This work was undertaken to identify the differences in expression of miRNAs, which would predict early-stage non-small cell lung cancer prognosis and recurrence. The results may be helpful to demonstrate one mechanism of lung squamous cancer proliferation.
METHODS: Lung squamous cell carcinoma specimens were collected at the time of surgery. Microarray of expression of specific miRNAs in lung squamous cell cancer tissue, were assessed by qRT-PCR.
RESULTS: We found that the hsa-mir-182 family are highly expressed in lung squamous cell carcinoma. Paradoxically, our study reveals mir-182 suppresses cell proliferation in vivo. RASA1 is related to cell apoptosis. We further show that mir-182 downregulates RASA1.
CONCLUSIONS: We provide first time evidence through tissue microarray and quantitative PCR validation of mir-182 in the expression of lung squamous cell carcinoma. Our data provide a possible mechanism for lung cancer cell proliferation in lung squamous cell cancer and may be helpful in discovering a new strategy to reveal lung squamous cell carcinoma progress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24600991     DOI: 10.7754/clin.lab.2013.121131

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  17 in total

1.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  miR-183 inhibits invasion of gastric cancer by targeting Ezrin.

Authors:  Long-Long Cao; Jian-Wei Xie; Yao Lin; Chao-Hui Zheng; Ping Li; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Qi-Yue Chen; Chang-Ming Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  miR-188-5p promotes oxaliplatin resistance by targeting RASA1 in colon cancer cells.

Authors:  Xijia Zhu; Xishun Luo; Zhike Song; Shiyu Jiang; Xiangkai Long; Xueyuan Gao; Xinyang Xie; Laijian Zheng; Haipeng Wang
Journal:  Oncol Lett       Date:  2021-04-20       Impact factor: 2.967

Review 5.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

Review 6.  Roles of miR-182 in sensory organ development and cancer.

Authors:  Qing Wei; Rong Lei; Guohong Hu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

7.  The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.

Authors:  Jun Hu; Guohua Lv; Shuguang Zhou; Yucheng Zhou; Bangxu Nie; Hong Duan; Yunfeng Zhang; Xiaofeng Yuan
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

8.  MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia.

Authors:  Yujiao Xing; Jianhua Fu; Haiping Yang; Li Yao; Lin Qiao; Yanna Du; Xindong Xue
Journal:  Int J Mol Med       Date:  2015-09-17       Impact factor: 4.101

Review 9.  Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis.

Authors:  Yi Ma; A-Juan Liang; Yu-Ping Fan; Yi-Ran Huang; Xiao-Ming Zhao; Yun Sun; Xiang-Feng Chen
Journal:  Oncotarget       Date:  2016-07-05

10.  Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells.

Authors:  Chunling Liu; Huan Guo; Xinxin Cheng; Mingming Shao; Chen Wu; Suhan Wang; Hongmin Li; Lixuan Wei; Yanning Gao; Wen Tan; Shujun Cheng; Tangchun Wu; Dianke Yu; Dongxin Lin
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.